Vertex Pharmaceuticals Incorporated
GCN2 inhibitors and uses thereof
Last updated:
Abstract:
The present invention provides compounds inhibiting General amino acid Control Non-derepressible 2 kinase ("GCN2"), compositions thereof, and methods of using the same for treating various disorders, such as cancer.
Status:
Grant
Type:
Utility
Filling date:
28 Jan 2019
Issue date:
27 Apr 2021